DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Hijazi Z, Wallentin L, Siegbahn A. et al.
N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation).
J Am Coll Cardiol 2013;
61 (22) 2274-2284
We do not assume any responsibility for the contents of the web pages of other providers.